🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lee Ratner

Washington University in St. Louis

ORCID: 0000-0003-2744-7294
Immunology and MicrobiologyAgricultural and Biological SciencesMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)”.

Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)

Blood(2020)10.1182/blood.2019003959
N/A
2.1DataRank · unranked
70 citations

Joseph A. Sparano, Amy Chadburn, Erin Reid, Richard F. Ambinder, Eric R. Siegel +13 more

Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial

The Lancet Haematology(2023)10.1016/s2352-3026(23)00157-6
N/A
0.847DataRank · unranked
32 citations

Page C. Moore, Milan Bimali, Jeanette Y. Lee, Michelle A. Rudek, Amy Chadburn +22 more

Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

Blood(2022)10.1182/blood.2022016534
N/A
0.673DataRank · unranked
88 citations

Kostiantyn Dreval, Daniela S. Gerhard, Laura K. Hilton, Jeremy S. Abramson, Richard F. Ambinder +63 more

Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma

Haematologica(2020)10.3324/haematol.2019.243386
N/A
0.425DataRank · unranked
16 citations

Jeannette Y. Lee, Lawrence D. Kaplan, Juan Carlos Ramos, Richard F. Ambinder, William Wachsman +8 more

Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study

The Oncologist(2022)10.1093/oncolo/oyac004
N/A
0.317DataRank · unranked
5 citations

Page C. Moore, Milan Bimali, Timothy P. Cooley, Joseph A. Sparano, Michelle A. Rudek +7 more

Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study

Cancer(2023)10.1002/cncr.35110
N/A
0DataRank · unranked
18 citations

Chia-Ching J. Wang, Himanshu Joshi, Shelly Lensing, Jeannette Y. Lee, Juan Carlos Ramos +14 more

Clinical characteristics and outcomes of infection with human T-lymphotropic virus in a non-endemic area: a single institution study

Frontiers in Microbiology(2023)10.3389/fmicb.2023.1187697
N/A
0DataRank · unranked
1 citations

Feng Gao, Sneha Poondru, Theodore Thomas, Lee Ratner, Margery Gang

Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087)

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1142
N/A
0DataRank · unranked
3 citations

Jeannette Y. Lee, Elizabeth Y. Chiao, David M. Aboulafia, Lee Ratner, Richard F. Ambinder +6 more

An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbits

Journal of Virology(2024)10.1128/jvi.01623-23
N/A
0DataRank · unranked
9 citations

Emily King, Victoria Maksimova, Susan M. Smith, Ramon Macias, Xiaogang Cheng +8 more

Role of the CTCF Binding Site in Human T-Cell Leukemia Virus-1 Pathogenesis

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.05.28.596170
N/A
0DataRank · unranked
0 citations

Xiaogang Cheng, John C. S. Harding, Jacob Al-Saleem, Patrick Green, Deborah J. Veis +3 more

Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma

Retrovirology(2020)10.1186/s12977-020-00535-z
N/A
0DataRank · unranked
16 citations

Sydney L. Olson, John C. S. Harding, Hemalatha Sundaramoorthi, Youngsoo Kim, Tianyuan Zhou +4 more

Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/Lymphoma

Nanomaterials(2021)10.3390/nano11061582
N/A
0DataRank · unranked
12 citations

John C. S. Harding, Lee Ratner, Samuel A. Wickline, Hua Pan, Daniel A. Rauch

Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19

Journal of Virology(2022)10.1128/jvi.00057-22
N/A
0DataRank · unranked
29 citations

Mijia Lu, Min Shi, Xiaogang Cheng, Kristin A. Kwakwa, Jennifer L. Davis +14 more

Phase I dose escalation and expansion study of defactinib, pembrolizumab, and gemcitabine in patients with advanced treatment-refractory pancreatic cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4146
N/A
0DataRank · unranked
1 citations

Kian-Huat Lim, Robert R. McWilliams, Rama Suresh, A. Craig Lockhart, Amberly Brown +15 more